Tokyo, May 15 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061569) titled 'Retrospective Observational Study Evaluating the Efficacy and Safety of Needle Radiofrequency Treatment Performed as Routine Clinical Practice for Male Androgenetic Alopecia and Female Pattern Hair Loss' on May 14.
Study Type:
Observational
Primary Sponsor:
Institute - Tokyo Midtown Clinic
Condition:
Condition - Male Androgenetic Alopecia and Female Pattern Hair Loss
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To evaluate the efficacy and safety of needle RF for MAGA and FPHL
Basic objectives2 - Safety,Efficacy
Eligibility:
Age-lower limit - 20
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Patients diagnosed with MAGA or FPHL at our institution during the study period
Patients who underwent needle RF treatment as routine clinical practice
Patients with available clinical scalp photographs and trichoscopic images obtained before and after treatment
Key exclusion criteria - Patients diagnosed with alopecia other than MAGA/FPHL
Patients with alopecia associated with collagen diseases, thyroid disorders, infections, or malignancies
Patients with scalp disorders affecting evaluation, including seborrheic dermatitis, tinea capitis, or atopic dermatitis
Cases with insufficient clinical photographs or trichoscopic images for evaluation
Cases with insufficient medical records for analysis
Target Size - 50
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2021 Year 05 Month 21 Day
Date of IRB - 2021 Year 05 Month 21 Day
Anticipated trial start date - 2021 Year 05 Month 21 Day
Last follow-up date - 2028 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000070379
Disclaimer: Curated by HT Syndication.
